279 related articles for article (PubMed ID: 23350857)
1. Drug-induced liver injury in the Australian setting.
Sistanizad M; Peterson GM
J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
4. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Siramolpiwat S; Sakonlaya D
Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.
Lin J; Moore D; Hockey B; Di Lernia R; Gorelik A; Liew D; Nicoll A
Liver Int; 2014 Apr; 34(4):576-82. PubMed ID: 23944929
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.
Cano-Paniagua A; Amariles P; Angulo N; Restrepo-Garay M
Ann Hepatol; 2019; 18(3):501-507. PubMed ID: 31053545
[TBL] [Abstract][Full Text] [Related]
9. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
Tsung I; Dolan R; Lao CD; Fecher L; Riggenbach K; Yeboah-Korang A; Fontana RJ
Aliment Pharmacol Ther; 2019 Oct; 50(7):800-808. PubMed ID: 31309615
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty.
Mitchell SJ; Hilmer SN; Murnion BP; Matthews S
J Clin Pharm Ther; 2011 Jun; 36(3):327-35. PubMed ID: 21545612
[TBL] [Abstract][Full Text] [Related]
11. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
[TBL] [Abstract][Full Text] [Related]
13. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.
De Valle MB; Av Klinteberg V; Alem N; Olsson R; Björnsson E
Aliment Pharmacol Ther; 2006 Oct; 24(8):1187-95. PubMed ID: 17014577
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced Liver Injury Is a Major Risk for New Drugs.
Seeff LB
Dig Dis; 2015; 33(4):458-63. PubMed ID: 26159259
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predisposing factors for flucloxacillin-related hepatotoxicity in children.
Coombs S; Pittet LF; Tang K; Gwee A
J Antimicrob Chemother; 2023 Nov; 78(11):2667-2671. PubMed ID: 37699070
[TBL] [Abstract][Full Text] [Related]
19. Acute liver enzyme elevations in HIV-1-infected patients.
Livry C; Binquet C; Sgro C; Froidure M; Duong M; Buisson M; Grappin M; Quantin C; Portier H; Chavanet P; Piroth L
HIV Clin Trials; 2003; 4(6):400-10. PubMed ID: 14628283
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathologic features of fluoroquinolone-induced liver injury.
Orman ES; Conjeevaram HS; Vuppalanchi R; Freston JW; Rochon J; Kleiner DE; Hayashi PH;
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):517-523.e3. PubMed ID: 21356330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
